ArticleJournal of cellular and molecular medicine2019

MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.

Chaoyong Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.